Advancing regulatory science in the EU – new strategy adopted

EMA has now published its Regulatory Science Strategy to 2025; stating the ongoing COVID-19 pandemic underlines the need for rapid engagement of all stakeholders & partners involved in development and supervision of medicines in the European Union and globally.


European Medicines Agency